Loading...

CCR9-CCL25 interactions promote cisplatin resistance in breast cancer cell through Akt activation in a PI3K-dependent and FAK-independent fashion

BACKGROUND: Chemotherapy heavily relies on apoptosis to kill breast cancer (BrCa) cells. Many breast tumors respond to chemotherapy, but cells that survive this initial response gain resistance to subsequent treatments. This leads to aggressive cell variants with an enhanced ability to migrate, inva...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Johnson-Holiday, Crystal, Singh, Rajesh, Johnson, Erica L, Grizzle, William E, Lillard, James W, Singh, Shailesh
Format: Artigo
Sprog:Inglês
Udgivet: BioMed Central 2011
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3110128/
https://ncbi.nlm.nih.gov/pubmed/21539750
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1477-7819-9-46
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!